Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Future of BioSciences, The' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Future of BioSciences; The Four Scenarios for 2020 and Their Implications for Human Healthcare |
June 2006 | £915 | 100 % |
|
Cancer Personalized Medicine 2008 |
July 2008 | £2425 | 50 % |
|
Prostate and Breast Cancer New Treatments & Developmental Progress |
March 2007 | £2025 | 41 % |
|
World Market for Sexual Disorders, 2005-2012, The Traversing New Frontiers in Sexual Chemistry |
January 2006 | £1900 | 34 % |
|
Ion Channel Drug Discovery Therapeutic Opportunities & Technology Progress |
May 2004 | £855 | 32.5 % |
|
Akzo Nobel Prospects to 2010 |
October 2006 | £795 | 31.5 % |
|
Breast Cancer - Therapeutic And Competitive Insights |
February 2007 | £1340 | 28.5 % |
|
Breast Cancer Therapeutic And Competitive Insights |
February 2007 | £1340 | 28.5 % |
|
Schering-Plough Pipeline ,Products ,Performance ,Potential |
August 2008 | £595 | 28.5 % |
|
Taiwan Pharmaceuticals and Healthcare Report Q2 2009 |
April 2009 | £250 | 24.5 % |
|
The True State of the Pharmaceutical Industry |
December 2008 | £495 | 23.5 % |
|
The Future of Biobanks Regulation, ethics, investment and the humanization of drug discovery |
March 2009 | £2025 | 21 % |
|
Drug Delivery Technology: Revolutionizing Cardiovascular Therapies |
July 2007 | £945 | 20.5 % |
|
Cancer Biomarkers: Players, products and prospects (Volume I) |
August 2008 | £595 | 17.5 % |
|
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects |
August 2008 | £1495 | 17.5 % |
|
Early Toxicology Markets and Approaches |
June 2007 | £2130 | 17.15 % |
|
Lateral Flow Technology and the Future of Point of Care Diagnostics |
February 2007 | £1825 | 17 % |
|
Drug Repositioning A market analysis |
March 2006 | £1095 | 16.1 % |
|
Cell-Based Diagnostics: Technology, Applications, and Markets 2nd Edition |
November 2007 | £2435 | 14.7 % |
|
Innovations in Diagnostics |
September 2006 | £1495 | 14.35 % |
|
Option & Evaluation Agreements in Pharma and Biotech |
March 2009 | £995 | 14 % |
|
Innovations and Trends in Clinical Trials Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology |
March 2007 | £1375 | 13.65 % |
|
Impact of Pharmacogenomics on Public Healthcare Policy Educating Patients, Payors and Healthcare Providers |
March 2008 | £1995 | 13.3 % |
|
Pipeline Insight Therapeutic Cancer Vaccines A turbulent path from bench to bedside |
October 2007 | £3010 | 12.95 % |
|
Royalty Financing Agreements in Pharma, Biotech and Diagnostics |
January 2009 | £495 | 12.6 % |
|
Global Market for Sleep-Wake Disorders, 2005-2012, The Trends, Opportunities, and Insights in a High-Value CNS Therapy Area |
December 2005 | £1100 | 12.25 % |
|
Emerging Opportunities in Cancer Nanomedicine |
August 2006 | £995 | 11.9 % |
|
Product and Asset Purchase Agreements in Pharma, Biotech and Diagnostics |
November 2008 | £1195 | 11.9 % |
|
World Market for Molecular Diagnostics, The |
January 2009 | £2435 | 11.55 % |
|
Biomarkers: The Future of Next-Generation Drug R&D |
September 2008 | £1585 | 11.2 % |
|
DNA Sequencing and PCR Markets |
July 2008 | £2075 | 11.2 % |
|
DNA Sequencing: Emerging Technologies and Applications |
January 2008 | £2960 | 10.5 % |
|
Comparison of Pharma Outsourcing between China and India |
July 2009 | £915 | 10.5 % |
|
Pipeline Insight Migraine Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries |
November 2007 | £3010 | 10.5 % |
|
Cardiovascular Biomarkers: Players, products and prospects (Volume III) |
August 2008 | £595 | 10.5 % |
|
Multiplex Assays in Translational Medicine Technologies, Applications, and Future Directions |
February 2008 | £685 | 10.15 % |
|
Stakeholder Opinions Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies |
July 2008 | £3800 | 10.15 % |
|
Cardiotoxicity: Issues, Technologies, and Solutions for the Future |
May 2008 | £2290 | 10.15 % |
|
Drug Discovery Tools for High-Content Analysis |
July 2007 | £1220 | 9.8 % |
|
Diagnostics and Therapeutics for Genetic Diseases |
April 2006 | £2960 | 9.8 % |
|
Medical Nanotechnology Markets |
September 2008 | £2075 | 9.45 % |
|
Liquid Chromatography Markets (LC, HPLC and UHPLC) |
March 2003 | £2135 | 9.45 % |
|
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics |
February 2009 | £1195 | 9.45 % |
|
Cell-Based Assays for Drug Discovery |
January 2009 | £2075 | 9.1 % |
|
Nanotechnology Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics |
January 2008 | £1995 | 8.75 % |
|
Cancer Therapies: Technologies and Global Markets |
January 2008 | £2960 | 8.75 % |
|
Cell Culture: The World Market for Media, Sera and Reagents 2nd Edition |
May 2005 | £2435 | 8.4 % |
|
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape |
October 2007 | £1830 | 8.4 % |
|
Physician Office Laboratory (POL) Testing Markets Worldwide Status Quo and Future Trends |
May 2007 | £2135 | 8.05 % |
|
In Vitro Diagnostics in a Recession IVD Market Forecasts, Analysis and Success Strategies |
May 2009 | £1825 | 8.05 % |
|
Schering-Plough Corporation PharmaVitae Profile |
July 2008 | £3010 | 8.05 % |
|
Companion Diagnostics in Personalized Medicine and Cancer Therapy |
April 2008 | £2075 | 8.05 % |
|
United States Diabetes Care Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Glucose Monitoring and Insulin Delivery Devices, Equipment and Supplies |
April 2008 | £1830 | 7.7 % |
|
Competitive Outlook on HCV What to Know & Expect in R&D and Business Development |
June 2004 | £855 | 7.7 % |
|
The Worldwide Market for Cancer Diagnostics 3rd Edition |
March 2008 | £2435 | 7.35 % |
|
World Market for Prescription Gastrointestinal Drugs, The |
July 2006 | £2135 | 7.35 % |
|
World Market for Prescription Generic Drugs; The 5th Edition |
April 2006 | £2135 | 7.35 % |
|
World Market for Pain Management Drugs and Devices 2nd Edition |
December 2006 | £2135 | 7.35 % |
|
Emerging Cancer Vaccine Market, The 2nd Edition |
November 2006 | £2135 | 7.35 % |
|
Pharmaceutical Outsourcing Opportunities Post Launch Contract Manufacturing, and Sales and Marketing,2nd Edition |
September 2006 | £2380 | 7.35 % |
|
Medical and Biological Sensors and Sensor Systems Markets, Applications, and Competitors Worldwide, 2nd Edition |
May 2006 | £2135 | 7.35 % |
|
The Impact of the Phase III Pipeline Future Projections and Market Disruptions |
March 2006 | £2135 | 7.35 % |
|
Global Market for Adjunctive Therapies in Cancer, The 2nd Edition |
April 2006 | £2135 | 7.35 % |
|
World Market for Psychotherapeutic Drugs, The |
January 2007 | £2135 | 7.35 % |
|
World Market for Prescription Respiratory Drugs, The |
October 2006 | £2135 | 7.35 % |
|
World Market for Prescription Orthopedic Drugs, The |
October 2006 | £2135 | 7.35 % |
|
Molecular Diagnostics Markets |
September 2008 | £2075 | 7 % |
|
Bioinformatics Technical Status and Market Prospects |
August 2005 | £2960 | 7 % |
|
Bioinformatics Markets Strategies, Business Models and Trends for the Future |
March 2009 | £2075 | 7 % |
|
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy |
July 2007 | £1999 | 6.65 % |
|
Pharmacogenomics: New Technologies In the Development of Personalized Therapies |
August 2005 | £2960 | 6.65 % |
|
Nanomedicine 2006-2011 |
June 2006 | £1499 | 6.65 % |
|
Hematology Analyzer Instrumentation and Reagent Markets |
January 2007 | £2075 | 6.65 % |
|
The Worldwide Market for In Vitro Diagnostic Tests 6th Edition [with 2009 Economy Preface] |
May 2008 | £2435 | 6.3 % |
|
Labeling and Linkage Agents for Immunoassays and Gene Probes |
April 2006 | £2960 | 6.3 % |
|
CNS Drug Discoveries What the Future Holds |
November 2006 | £1995 | 6.3 % |
|
Clinical Trials Business; The |
August 2006 | £2960 | 5.95 % |
|
Global Vaccines Market 2008-2023, The |
August 2008 | £1499 | 5.95 % |
|
Pipeline/Commercial Insight: Supportive Care in Oncology Significant growth opportunities exist in new supportive care indications |
June 2007 | £7600 | 5.95 % |
|
Stakeholder Opinions: Primary Brain Cancer Temozolomide Turns Heads |
July 2007 | £2005 | 5.95 % |
|
The Global Market for Advanced Wound Care Products 2007 |
May 2009 | £795 | 5.95 % |
|
Antiageing and Life Enhancement Pharmacotherapeutics |
January 2006 | £4600 | 5.95 % |
|
Companion Biomarkers in Drug Development |
April 2009 | £2075 | 5.95 % |
|
Biomedical Imaging From Drug Target Discovery to Medical Diagnostics |
December 2008 | £2290 | 5.95 % |
|
Global Antivirals Market Analysis & Forecasts 2008-2023 |
September 2008 | £1499 | 5.6 % |
|
Antiseptics and Disinfectants |
February 2009 | £2960 | 5.6 % |
|
In Vitro Diagnostics Market Report & Analysis 2008-2023 |
June 2008 | £1499 | 5.6 % |
|
Global Diabetes Market; The Therapeutics, Diagnostics and Complications |
August 2006 | £1525 | 5.6 % |
|
The Market for In Vitro Toxicology Testing |
March 2007 | £2960 | 5.25 % |
|
Drug-Device Combinations |
June 2005 | £2960 | 5.25 % |
|
Epigenomics Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics |
March 2007 | £2960 | 5.25 % |
|
Cell Therapy Markets |
July 2007 | £2075 | 4.9 % |
|
Pediatric Health Care Products and Services |
March 2009 | £2960 | 4.55 % |
|
Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities |
April 2006 | £1900 | 4.55 % |
|
Pipeline Insight: Cancer Overview Increasing Diversity Offers Both High Risk And Reward |
September 2007 | £7600 | 4.2 % |
|
Stakeholder Opinions: Acute Leukemias Persistent unmet needs confer significant commercial opportunity |
April 2006 | £2170 | 4.2 % |
|
Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry |
April 2009 | £6000 | 3.85 % |
|
Cancer Diagnostic Testing World Markets |
April 2008 | £2075 | 3.85 % |
|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies |
April 2008 | £2075 | 3.85 % |
|
Medtronic Medical Device Company Intelligence Report |
September 2006 | £495 | 3.85 % |
|
Biomarkers The Expanding Global Market |
November 2007 | £2960 | 3.5 % |
|
Clinical Laboratory Testing Volume 1: Reagents and Instruments |
April 2009 | £2075 | 3.5 % |
|
Sleep Disorders Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking |
March 2009 | £2075 | 3.15 % |
|
Global Market for Advanced Wound Care Products 2008, The A complete review of this fast growing, highly innovative sector |
April 2008 | £695 | 1.75 % |
